Cheaper Drugs in Foreign Markets Increase the Focus on Domestic Drug Prices

Annals of Internal Medicine

Volumn 140, Issue 8, 2004, Pages 677-680

  Wilson, Jennifer Fisher ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; ATORVASTATIN; CARBAMAZEPINE; CELECOXIB; CLONAZEPAM; DIAZEPAM; DRUG; FLUTICASONE PROPIONATE; GENERIC DRUG; ISOTRETINOIN; LITHIUM; LORAZEPAM; METFORMIN; SILDENAFIL; SIMVASTATIN; TAMOXIFEN; UNCLASSIFIED DRUG; WARFARIN;

CANADA; COMMERCIAL PHENOMENA; DRUG COST; DRUG IMPORTATION; DRUG INDUSTRY; DRUG LEGISLATION; DRUG MARKETING; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; FREE TRADE; GOVERNMENT REGULATION; LAW; PRESCRIPTION DRUG; PRICE CONTROL; PRIORITY JOURNAL; REVIEW; UNITED STATES;

EID: 11144303721     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-140-8-200404200-00044     Document Type: Review

References (3)

1. Wagner JL, McCarthy E. International differences in drug prices. Annu Rev Public Health. Accessed at http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.publhealth.25. 101802. 123042 on 4 March 2004.
2. Danzon PM, Furukawa MF. Prices and availability of pharmaceuticals: evidence from nine countries. Health Affairs. Accessed at http://content .healthaffairs.org/cgi/content/full/hlthaff.w3.521v1/DC1 on 4 March 2004.
3. Calfee JE. The grim economics of pharmaceutical importation. Health Policy Outlook. November 2003.